These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24599802)

  • 1. Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
    Limmer S; Hahn J; Schmidt R; Wachholz K; Zengerle A; Lechner K; Eibl H; Issels RD; Hossann M; Lindner LH
    Pharm Res; 2014 Sep; 31(9):2276-86. PubMed ID: 24599802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPPG
    van Valenberg FJP; Brummelhuis ISG; Lindner LH; Kuhnle F; Wedmann B; Schweizer P; Hossann M; Witjes JA; Oosterwijk E
    Int J Nanomedicine; 2021; 16():75-88. PubMed ID: 33447028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes.
    Rysin A; Paal M; Lokerse WJM; Wedmann B; Hossann M; Vogeser M; Winter G; Lindner LH
    Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183698. PubMed ID: 34283999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
    Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
    Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study.
    Lokerse WJM; Lazarian A; Kleinhempel A; Petrini M; Schwarz P; Hossann M; Holdt LM; Mailänder V; Lindner LH
    J Control Release; 2021 May; 333():1-15. PubMed ID: 33741385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific delivery of gemcitabine with activatable liposomes.
    Tucci ST; Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Foiret J; Hubbard NE; Borowsky AD; Baikoghli M; Cheng RH; Ferrara KW
    J Control Release; 2019 Sep; 309():277-288. PubMed ID: 31301340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPPG
    Brummelhuis ISG; Simons M; Lindner LH; Kort S; de Jong S; Hossann M; Witjes JA; Oosterwijk E
    Int J Hyperthermia; 2021; 38(1):1415-1424. PubMed ID: 34581259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of 2',2'difluorodeoxycytidine (Gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo.
    Van Bree C; Beumer C; Rodermond HM; Haveman J; Bakker PJ
    Int J Hyperthermia; 1999; 15(6):549-56. PubMed ID: 10598951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
    Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
    Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or Excipients.
    Rysin A; Lokerse WJM; Paal M; Habler K; Wedmann B; Hossann M; Winter G; Lindner LH
    J Pharm Sci; 2023 Jul; 112(7):1947-1956. PubMed ID: 37030437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma.
    Zimmermann K; Hossann M; Hirschberger J; Troedson K; Peller M; Schneider M; Brühschwein A; Meyer-Lindenberg A; Wess G; Wergin M; Dörfelt R; Knösel T; Schwaiger M; Baumgartner C; Brandl J; Schwamberger S; Lindner LH
    Int J Hyperthermia; 2017 Mar; 33(2):178-190. PubMed ID: 27592502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.
    Moog R; Burger AM; Brandl M; Schüler J; Schubert R; Unger C; Fiebig HH; Massing U
    Cancer Chemother Pharmacol; 2002 May; 49(5):356-66. PubMed ID: 11976829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
    Gamblin TC; Egorin MJ; Zuhowski EG; Lagattuta TF; Herscher LL; Russo A; Libutti SK; Alexander HR; Dedrick RL; Bartlett DL
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):647-53. PubMed ID: 18040687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.
    Beumer JH; Eiseman JL; Parise RA; Joseph E; Covey JM; Egorin MJ
    Clin Cancer Res; 2008 Jun; 14(11):3529-35. PubMed ID: 18519786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
    Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z
    J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.